By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


Company News
Tocagen Inc. Expands Clinical Development Team 8/26/2014 9:09:57 AM
Data for Tocagen Inc.'s Toca 511 Presented At The American Society Of Gene And Cell Therapy Annual Meeting 5/22/2014 7:11:23 AM
Tocagen Inc. Names Jamey Skillings, M.D., Chief Medical Officer 3/25/2014 7:07:00 AM
Data Presented At Society For Neuro-Oncology Annual Meeting Demonstrate Tocagen Inc.'s Toca 511 Gene Therapy With Toca FC Was Well Tolerated And Showed Antitumor Activity In Patients With High Grade Glioma 11/26/2013 7:26:57 AM
Voices Against Brain Cancer Awards Grant to Tocagen Inc. to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 6/20/2013 8:57:43 AM
Advancing Neuroscience: IMRIS, MRI Interventions, Inc. (MRIC) and Tocagen Inc. Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors 5/31/2013 9:37:33 AM
MRI Interventions, Inc. (MRIC) Release: Tocagen Inc. to Utilize ClearPoint® Neuro Intervention System for MRI-guided Delivery of Toca 511 in a Study of Patients With Brain Cancer 6/25/2012 10:32:28 AM
Siemens Healthcare Diagnostics Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen Inc. 2/8/2012 8:40:54 AM
Tocagen Inc. Release: Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC 2/3/2012 9:00:14 AM
Tocagen Inc.'s First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma 6/7/2011 9:49:29 AM